Market Trends of Biotechnology Industry
Healthcare Segment is Expected to Hold a Significant Market Share
- There is a rising demand for advanced and effective treatments for chronic diseases, genetic disorders, and age-related conditions. Biotechnology offers innovative solutions, such as biopharmaceuticals and personalized medicine, which are tailored to individual patient needs. This demand drives investment and research in biotechnological advancements.
- The increasing number of bladder cancers is creating a demand for advanced diagnosis techniques. According to the American Cancer Society, around 83,190 new cases of bladder cancer are expected to be registered in the United States in 2024, and around 16,840 people are anticipated to die from bladder cancer.
- Many governments are increasing their support for biotechnology through funding, favorable regulations, and initiatives to foster innovation. This support helps create a conducive environment for research and development, encouraging companies to invest in biotechnology.
- The United States and India announced a partnership for rapid drug discovery. The two countries have cooperated previously in critical areas such as disease control and surveillance, laboratory integration, and enhancement of public health capacities. In recent years, that collaboration has intensified, especially in the field of biotechnology. Joint efforts now focus on using artificial intelligence (AI) to match patients with treatments, applying nanotechnology for targeted drug delivery, and improving bioinformatic tools for comprehensive data analysis.
Understand The Key Trends Shaping This Market
Download PDF
North America to Expected to Hold the Largest Market Share
- North America, particularly the United States, boosts a strong R&D ecosystem supported by leading universities, research institutions, and biotechnology firms. This infrastructure fosters innovation and accelerates the development of new biotechnological products and therapies, making it a hub for biotechnology advancements.
- Furthermore, the region has one of the highest healthcare expenditures globally, translating into significant biotechnology investments. This financial commitment supports the development of new treatments, diagnostics, and technologies, driving demand for biotechnological solutions in healthcare.
- A rising consumer preference for healthier, more nutritious food options exists. Biotechnology enables the development of biofortified crops enriched with vitamins and minerals, addressing nutritional deficiencies and enhancing overall health. This trend is particularly important as consumers become more health-conscious and seek products that offer functional benefits.
- USDA's research aims to leverage biotechnology and biomanufacturing to expand opportunities for US agricultural producers while addressing critical challenges such as climate change, nutritional insecurity, environmental justice, emerging diseases and pests, and increasing global competition.
- President Biden signed an Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy to support these initiatives. This order has spurred government action to set ambitious goals, develop the biomanufacturing workforce, promote American leadership in biotechnology research and development, and ensure responsible development and use of these technologies. Since the start of the Biden-Harris Administration, the President's commitment to a clean energy economy has resulted in USD 29 billion in public and private sector biomanufacturing investments for projects across the country.
Get Analysis on Important Geographic Markets
Download PDF
